Global perspective of key studies presented at ASCO, EHA, ICML 2021 from an international expert in CLL from Clinical Care Options (CCO)
Analysis of key studies in hematologic malignancies from ASCO 2021 presented by Drs. Ian Flinn, Shaji Kumar, and Eunice Wang, as reported by Clinical Care Options (CCO)
Download this summary on the management of adverse events associated with BTK inhibitors, from Clinical Care Options (CCO).
On-demand webcast on the current treatment paradigm in mantle cell lymphoma featuring 3 faculty experts presented by Clinical Care Options (CCO)